Oruka Therapeutics, Inc. (ORKA) Reports Q3 Loss of $1.46
Tweet
Share
E-mailGet Alerts ORKA Hot Sheet
Join SI Premium – FREE
Oruka Therapeutics, Inc. (NASDAQ: ORKA) reported Q3 EPS of ($1.46).
For earnings history and earnings-related data on Oruka Therapeutics, Inc. (ORKA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart to pay $1.4 billion for Vibe.co acquisition - WSJ
- Wealthfront launches custodial account with tax-gain harvesting
- Tenable Holdings, Inc. (TENB) call put ratio 80 calls to 1 put with a focus on 200 contracts of July 32 calls as share price up 5.6%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
